v3.26.1
Shareholders' Equity - Shareholders' Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance, beginning of period $ (714)  
Foreign currency translation adjustment (10) $ (13)
Net income (loss) – discontinued operations 363 (2,020)
Net loss – continuing operations (850) (814)
Balance, end of period 532 19,514
Foreign currency translation adjustment (10) (13)
Net income (loss) – discontinued operations 363 (2,020)
Net loss – continuing operations (850) (814)
Preferred stock, common stock and additional paid-in capital [Member]    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance, beginning of period 35,769 31,696
Return of dividend 6 0
Repurchase of warrants (22) 0
Issuance of common stock and warrants, net 1,750 1,000
Share-based compensation expense 0 23
Proceeds from employee stock purchase plan 0 7
Balance, end of period 37,503 32,726
Return of dividend 6 0
Repurchase of warrants (22) 0
Issuance of common stock and warrants, net 1,750 1,000
Share-based compensation expense 0 23
Proceeds from employee stock purchase plan 0 7
Accumulated other comprehensive loss [Member]    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance, beginning of period (340) (306)
Foreign currency translation adjustment (1) (13)
Balance, end of period (341) (319)
Foreign currency translation adjustment (1) (13)
Accumulated deficit [Member]    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance, beginning of period (36,143) (10,059)
Net income (loss) – discontinued operations 363 (814)
Net loss – continuing operations (850) (2,020)
Balance, end of period (36,630) (12,893)
Net income (loss) – discontinued operations 363 (814)
Net loss – continuing operations $ (850) $ (2,020)